These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23803172)

  • 1. Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumors.
    Weng H; Deng Y; Xie Y; Liu H; Gong F
    BMC Cancer; 2013 Jun; 13():311. PubMed ID: 23803172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of high mobility group protein box 1 and toll like receptor 4 pathway on warts caused by human papillomavirus.
    Weng H; Liu H; Deng Y; Xie Y; Shen G
    Mol Med Rep; 2014 Oct; 10(4):1765-71. PubMed ID: 25118798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of oxymatrine on
    Shi J; Ji R; Guan Z; Zhang X; Lu Y
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Jun; 36(3):286-293. PubMed ID: 38952315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of high mobility group B1 and toll-like receptor-nuclear factor κB signaling pathway in chronic subdural hematomas.
    Osuka K; Watanabe Y; Usuda N; Iwami K; Miyachi S; Takayasu M
    PLoS One; 2020; 15(6):e0233643. PubMed ID: 32479555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cucurbitacin E ameliorates lipopolysaccharide-evoked injury, inflammation and MUC5AC expression in bronchial epithelial cells by restraining the HMGB1-TLR4-NF-κB signaling.
    Shang J; Liu W; Yin C; Chu H; Zhang M
    Mol Immunol; 2019 Oct; 114():571-577. PubMed ID: 31525576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective effect of uric acid in reducing TLR4/NF-κB activation through the inhibition of HMGB1 acetylation in a model of ischemia-reperfusion injury in vitro.
    Cheng GM; Wang RL; Zhang B; Deng XY
    Mol Biol Rep; 2020 Apr; 47(4):3233-3240. PubMed ID: 32095984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selectively activating melanocortin 4 receptor acts against rat sepsis-induced acute liver injury via HMGB1/TLR4/NF-κB signaling pathway].
    Li H; Qiu D; Gao Q; Wang H; Sun M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1055-9. PubMed ID: 27412936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of HMGB1 A-box reduced lipopolysaccharide-induced intestinal inflammation via HMGB1/TLR4 signaling in vitro.
    Wang FC; Pei JX; Zhu J; Zhou NJ; Liu DS; Xiong HF; Liu XQ; Lin DJ; Xie Y
    World J Gastroenterol; 2015 Jul; 21(25):7764-76. PubMed ID: 26167076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Mobility Group Box 1 Overexpression Predicts a Poor Prognosis and Promotes Epithelial-Mesenchymal Transition in Gastric Cancer by Activating TLR4/NF-κB Signaling.
    Ma J; Da M
    Oncology; 2023; 101(12):786-798. PubMed ID: 37666221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR4-HMGB1-, MyD88- and TRIF-dependent signaling in mouse intestinal ischemia/reperfusion injury.
    Wang J; He GZ; Wang YK; Zhu QK; Chen W; Guo T
    World J Gastroenterol; 2015 Jul; 21(27):8314-25. PubMed ID: 26217083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal expression of Toll-like receptor 4 is associated with susceptibility to ethanol-induced gastric mucosal injury in mice.
    Ye HH; Hua R; Yu L; Wu KJ; Fei SJ; Qin X; Song Y; Cao JL; Zhang YM
    Dig Dis Sci; 2013 Oct; 58(10):2826-39. PubMed ID: 23744365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexmedetomidine Preconditioning Ameliorates Inflammation and Blood-Spinal Cord Barrier Damage After Spinal Cord Ischemia-Reperfusion Injury by Down-Regulation High Mobility Group Box 1-Toll-Like Receptor 4-Nuclear Factor κB Signaling Pathway.
    Liu J; Zhang S; Fan X; Yuan F; Dai J; Hu J
    Spine (Phila Pa 1976); 2019 Jan; 44(2):E74-E81. PubMed ID: 29975331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
    Zhai Y; Zhu Y; Liu J; Xie K; Yu J; Yu L; Deng H
    Med Sci Monit; 2020 Jan; 26():e918617. PubMed ID: 31912804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine Alleviates CCI-Induced Neuropathic Pain via Inhibiting HMGB1-Mediated Astrocyte Activation and the TLR4/NF-κB Signaling Pathway in Rats.
    Zhao E; Bai L; Li S; Li L; Dou Z; Huang Y; Li Y; Lv Y
    Neurotox Res; 2020 Oct; 38(3):723-732. PubMed ID: 32607919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Destruction in maternal-fetal interface of URSA patients via the increase of the HMGB1-RAGE/TLR2/TLR4-NF-κB signaling pathway.
    Zou H; Yin J; Zhang Z; Xiang H; Wang J; Zhu D; Xu X; Cao Y
    Life Sci; 2020 Jun; 250():117543. PubMed ID: 32169518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HMGB1 improves necrotizing enterocolitis by inhibiting NLRP3 via TLR4 and NF-κB signaling pathways.
    Yu R; Jiang S; Tao Y; Li P; Yin J; Zhou Q
    J Cell Physiol; 2019 Aug; 234(8):13431-13438. PubMed ID: 30618088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma.
    Suiqing C; Min Z; Lirong C
    J Dermatol; 2005 May; 32(5):354-60. PubMed ID: 16043897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroacupuncture modulated the inflammatory reaction in MCAO rats via inhibiting the TLR4/NF-κB signaling pathway in microglia.
    Han B; Lu Y; Zhao H; Wang Y; Li L; Wang T
    Int J Clin Exp Pathol; 2015; 8(9):11199-205. PubMed ID: 26617842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGB1 mediates microglia activation via the TLR4/NF-κB pathway in coriaria lactone induced epilepsy.
    Shi Y; Zhang L; Teng J; Miao W
    Mol Med Rep; 2018 Apr; 17(4):5125-5131. PubMed ID: 29393419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.
    Nguyen AH; Detty SQ; Agrawal DK
    Anticancer Res; 2017 Jan; 37(1):1-7. PubMed ID: 28011467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.